Nobili, Flavio http://orcid.org/0000-0001-9811-0897
,
Festari, Cristina
Altomare, Daniele
Agosta, Federica
Orini, Stefania
Van Laere, Koen
Arbizu, Javier
Bouwman, Femke
Drzezga, Alexander
Nestor, Peter
Walker, Zuzana
Boccardi, Marina
Article History
Received: 12 April 2018
Accepted: 16 April 2018
First Online: 2 May 2018
Compliance with ethical standards
:
: Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly and grants from Chiesi Farmaceutici.Cristina Festari: declares that she has no conflict of interest.Daniele Altomare: was the recipient of the grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Federica Agosta: is Section Editor of NeuroImage: Clinical; has received speaker fees from Biogen Idec, Novartis, and Excellence in Medical Education; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. She received personal fees from Elsevier INC.Stefania Orini: declares that she has no conflict of interest.Koen Van Laere: received grant support through KU Leuven from GE Healthcare, Merck, Janssen Pharmaceuticals, UCB, Novartis, Pfizer and Abide Therapeutics.Javier Arbizu: received grants from Eli Lilly & Co, Piramal, and GE Healthcare.Femke Bouwman: declares that she has no conflict of interest.Peter Nestor: declares that he has no conflict of interest.Alexander Drzezga: received grants and non-financial support from Eli-Lilly & Co, Siemens and GE Healthcare; he also received non-financial support from Piramal.Zuzana Walker: received from GE Healthcare grants and tracers, personal fees for consultancy and speaker’s fee.Marina Boccardi has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. Moreover, she has received research grants from Piramal and served as a paid member of advisory boards for Eli Lilly.
: This article does not contain any new studies with human participants or animals performed by any of the authors. The human studies discussed herein came exclusively from previously published research articles.
: Not applicable, this is a review article. Informed consent statement is declared in each of the revised paper.